| Product Code: ETC6144453 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Patient Derived Xenograft (PDX) Models Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 Argentina Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.7 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.9 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Argentina Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Argentina |
4.2.2 Growing demand for personalized medicine |
4.2.3 Rising investments in research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the use of patient-derived xenograft models |
4.3.2 Limited awareness and adoption of PDX models in Argentina |
4.3.3 High cost associated with PDX model development and maintenance |
5 Argentina Patient Derived Xenograft (PDX) Models Market Trends |
6 Argentina Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 Argentina Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2021- 2031F |
6.1.4 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2021- 2031F |
6.2 Argentina Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2021- 2031F |
6.2.3 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2021- 2031F |
6.2.4 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2021- 2031F |
6.3 Argentina Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2021- 2031F |
6.3.3 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2021- 2031F |
6.3.4 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2021- 2031F |
6.3.5 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2021- 2031F |
6.3.6 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2021- 2031F |
6.3.7 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2021- 2031F |
6.4 Argentina Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2021- 2031F |
6.4.3 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2021- 2031F |
6.5 Argentina Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2021- 2031F |
6.5.3 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.5.4 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2021- 2031F |
6.5.5 Argentina Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2021- 2031F |
7 Argentina Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 Argentina Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 Argentina Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 Argentina Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Average turnaround time for developing patient-derived xenograft models |
8.2 Number of collaborations between research institutions and pharmaceutical companies for PDX model research |
8.3 Percentage of successful preclinical trials using PDX models |
9 Argentina Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 Argentina Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Argentina Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.3 Argentina Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Argentina Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.5 Argentina Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Argentina Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 Argentina Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2024 |
10.2 Argentina Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here